238 related articles for article (PubMed ID: 23365445)
1. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2013 Apr; 87(8):4252-60. PubMed ID: 23365445
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2011 Mar; 85(5):2364-72. PubMed ID: 21177810
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Poliovirus Resistance to Host Phosphatidylinositol-4 Kinase III β Inhibitor.
Arita M
ACS Infect Dis; 2016 Feb; 2(2):140-8. PubMed ID: 27624965
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure.
Arita M
Microbiol Immunol; 2014 Apr; 58(4):239-56. PubMed ID: 24527995
[TBL] [Abstract][Full Text] [Related]
5. Poliovirus Evolution toward Independence from the Phosphatidylinositol-4 Kinase III β/Oxysterol-Binding Protein Family I Pathway.
Arita M; Bigay J
ACS Infect Dis; 2019 Jun; 5(6):962-973. PubMed ID: 30919621
[TBL] [Abstract][Full Text] [Related]
6. [Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection].
Arita M
Uirusu; 2013; 63(1):93-102. PubMed ID: 24769585
[TBL] [Abstract][Full Text] [Related]
7. Modulation of proteolytic polyprotein processing by coxsackievirus mutants resistant to inhibitors targeting phosphatidylinositol-4-kinase IIIβ or oxysterol binding protein.
Lyoo H; Dorobantu CM; van der Schaar HM; van Kuppeveld FJM
Antiviral Res; 2017 Nov; 147():86-90. PubMed ID: 29024767
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachypodol (Ro 09-0179) for their anti-poliovirus activities, and is located at upstream of the target step of brefeldin A.
Arita M; Philipov S; Galabov AS
Microbiol Immunol; 2015 Jun; 59(6):338-47. PubMed ID: 25891300
[TBL] [Abstract][Full Text] [Related]
9. Model of OSBP-Mediated Cholesterol Supply to Aichi Virus RNA Replication Sites Involving Protein-Protein Interactions among Viral Proteins, ACBD3, OSBP, VAP-A/B, and SAC1.
Ishikawa-Sasaki K; Nagashima S; Taniguchi K; Sasaki J
J Virol; 2018 Apr; 92(8):. PubMed ID: 29367253
[TBL] [Abstract][Full Text] [Related]
10. Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase IIIα and Oxysterol-Binding Protein.
Dorobantu CM; Albulescu L; Lyoo H; van Kampen M; De Francesco R; Lohmann V; Harak C; van der Schaar HM; Strating JR; Gorbalenya AE; van Kuppeveld FJ
mSphere; 2016; 1(3):. PubMed ID: 27303747
[TBL] [Abstract][Full Text] [Related]
11. A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection.
Arita M; Takebe Y; Wakita T; Shimizu H
J Gen Virol; 2010 Nov; 91(Pt 11):2734-44. PubMed ID: 20660150
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.
Spickler C; Lippens J; Laberge MK; Desmeules S; Bellavance É; Garneau M; Guo T; Hucke O; Leyssen P; Neyts J; Vaillancourt FH; Décor A; O'Meara J; Franti M; Gauthier A
Antimicrob Agents Chemother; 2013 Jul; 57(7):3358-68. PubMed ID: 23650168
[TBL] [Abstract][Full Text] [Related]
13. PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases.
Delang L; Harak C; Benkheil M; Khan H; Leyssen P; Andrews M; Lohmann V; Neyts J
J Antimicrob Chemother; 2018 Dec; 73(12):3375-3384. PubMed ID: 30219827
[TBL] [Abstract][Full Text] [Related]
14. Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds.
Roberts BL; Severance ZC; Bensen RC; Le-McClain AT; Malinky CA; Mettenbrink EM; Nuñez JI; Reddig WJ; Blewett EL; Burgett AWG
Antiviral Res; 2019 Oct; 170():104548. PubMed ID: 31271764
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication.
van der Schaar HM; van der Linden L; Lanke KH; Strating JR; Pürstinger G; de Vries E; de Haan CA; Neyts J; van Kuppeveld FJ
Cell Res; 2012 Nov; 22(11):1576-92. PubMed ID: 22945356
[TBL] [Abstract][Full Text] [Related]
16. Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime.
Arita M; Wakita T; Shimizu H
J Gen Virol; 2009 Aug; 90(Pt 8):1869-1879. PubMed ID: 19439558
[TBL] [Abstract][Full Text] [Related]
17. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.
Heinz BA; Vance LM
J Virol; 1995 Jul; 69(7):4189-97. PubMed ID: 7769678
[TBL] [Abstract][Full Text] [Related]
18. Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex.
Brown-Augsburger P; Vance LM; Malcolm SK; Hsiung H; Smith DP; Heinz BA
Arch Virol; 1999; 144(8):1569-85. PubMed ID: 10486111
[TBL] [Abstract][Full Text] [Related]
19. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
[TBL] [Abstract][Full Text] [Related]
20. High-Order Epistasis and Functional Coupling of Infection Steps Drive Virus Evolution toward Independence from a Host Pathway.
Arita M
Microbiol Spectr; 2021 Oct; 9(2):e0080021. PubMed ID: 34468191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
